Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
320 participants
OBSERVATIONAL
2018-04-17
2019-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Urinary Tract Infection in Pregnancy
NCT04244526
Treatment of Asymptomatic Bacteriuria in Pregnancy
NCT02911662
Safety of Antibiotic Intake During Pregnancy
NCT05810935
Management of Sub-Clinical Bacteriuria in Pregnancy
NCT03275623
Safety and Effectiveness of a Laboratory Intervention to Effectively NOT Treat Asymptomatic Bacteriuria
NCT03445312
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The pregnant women are two times more commonly affected than age matched non pregnant females. This is due to urinary stasis due to progesterone effect in pregnancy in addition to different morphological and physiological changes occurring during pregnancy The prevalence of ASB is about 3 times higher in diabetic women (ranging from 15% to 30%) than in non-diabetic women (less than 10%)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pregnant women in first Trimester
A urine sample will be taken from pregnant women before 14 weeks of pregnancy
urine analysis
Intervention is (urine analysis ): of a mid stream urine sample will be taken
pregnant women in second Trimester
A urine sample will be taken from pregnant women from 14 weeks +1 day till 28 weeks
urine analysis
Intervention is (urine analysis ): of a mid stream urine sample will be taken
pregnant women in third Trimester
A urine sample will be taken from pregnant women from 28 weeks +1 day till 40 weeks
urine analysis
Intervention is (urine analysis ): of a mid stream urine sample will be taken
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
urine analysis
Intervention is (urine analysis ): of a mid stream urine sample will be taken
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
17 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kasr El Aini Hospital
OTHER
Aljazeera Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahmoud Alalfy
Assistant Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahmoud Alalfy
Role: PRINCIPAL_INVESTIGATOR
Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Algazeerah
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ahmed Elgazzar, M.D
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A symptomatic bacteriuria
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.